Results 81 to 90 of about 2,311,361 (335)
The effect of Fingolimod on patients with moderate to severe COVID‐19
Pharmacology Research & Perspectives, 2023 Hyper‐inflammation, cytokine storm, and recruitment of immune cells lead to uncontrollable endothelial cell damage in patients with coronavirus disease 2019 (COVID‐19).
Soheil Teymouri +6 more
doaj +1 more source
Journal of the American Medical Association (JAMA), 2021 Importance The efficacy of vitamin D3 supplementation in coronavirus disease 2019 (COVID-19) remains unclear. Objective To investigate the effect of a single high dose of vitamin D3 on hospital length of stay in patients with COVID-19.
Igor H. Murai +16 more
semanticscholar +1 more source
Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions
Clinical Case Reports, 2021 Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis.
Zahra Heydarifard +4 more
doaj +1 more source
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
The Lancet Rheumatology, 2020 Background No therapy is approved for COVID-19 pneumonia. The aim of this study was to assess the role of tocilizumab in reducing the risk of invasive mechanical ventilation and death in patients with severe COVID-19 pneumonia who received standard of ...
G. Guaraldi +33 more
semanticscholar +1 more source
Severe COVID-19-Induced Hemophagocytic Lymphohistiocytosis
Cureus, 2023 We reported a case of secondary hemophagocytic lymphohistiocytosis (HLH), a rare and life-threatening condition, which was suspected to have been triggered by a severe case of coronavirus disease 2019 (COVID-19). A 50-year-old man with a past medical history of ulcerative colitis with recent pancolitis status post colectomy and ileostomy two weeks ...
Khan, Shahkar +4 more
openaire +2 more sources
Severe asthma in the era of COVID-19: A narrative review
Pulmonology, 2022 Introduction and objectives Severe asthma management during the coronavirus disease 2019 (COVID-19) pandemic is a challenge and will continue to be, at least in the next few months, as herd immunity is still a mirage.
João Gaspar-Marques +3 more
doaj +3 more sources
Severe infectious acute respiratory failure mimicking COVID‐19 in a healthy adolescent
Respirology Case Reports, 2022 A 15‐year‐old male presented with headache, high fever and respiratory distress. Chest computed tomography showed bilateral pneumonia, and antimicrobial therapy was initiated.
Kohei Hashimoto +5 more
doaj +1 more source
A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease. [PDF]
, 2020 Novel coronavirus disease 2019 (COVID-19) is a highly infectious, rapidly spreading viral disease with an alarming case fatality rate up to 5%.
Amin, Alpesh N +19 more
core +1 more source
Covid-19 and ecotourism prospect: Malaysia and Indonesia perspectives [PDF]
, 2022 The coronavirus (Covid 19) has a significant impact on all businesses in Asia, the Pacific region, and the rest of the world. Indeed, apart from health effects, the Covid 19 pandemic has significant economic effects worldwide.
Harun, Amran +1 more
core
Journal of the American Medical Association (JAMA), 2020 Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants An ongoing
D. Angus +55 more
semanticscholar +1 more source